Market Cap (In USD)
12.91 Million
Revenue (In USD)
34.77 Thousand
Net Income (In USD)
-2.54 Million
Avg. Volume
3341.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0245-0.0985
- PE
- -
- EPS
- -
- Beta Value
- -0.02
- ISIN
- CA82967M1005
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Howard J. Verrico M.D., Ph.D.
- Employee Count
- -
- Website
- https://www.sironabiochem.com
- Ipo Date
- 2013-02-12
- Details
- Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. Sirona Biochem Corp. has a research collaboration agreement with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop antiviral library of compounds. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.
More Stocks
-
000096
-
HPYCF
-
2344
-
155A
-
VCII
-
600269
-
QNI
-
INGR